By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – 20/20 GeneSystems, a Rockville, Md.-based firm developing companion diagnostics, today said that it has received $3 million in Small Business Innovative Research grants to develop tests to help oncologists predict the effectiveness of targeted cancer therapies.

The grants came from the National Cancer Institute's SBIR program and included a $2.75 million Phase IIB "Bridge Award," and a $200,000 Phase I SBIR contract.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.